跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gavamin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gavamin
Approved
STANDARD
Gavamin
Myungmoon Pharmaceutical Co., Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
adc42c821027aa98
Company
Myungmoon Pharmaceutical Co., Ltd
Type
Standard
Approval Details
Approval Id
adc42c821027aa98
Drug Approval Philippines Name
Gavamin
Product Name
Gavamin
Registration Number
DRP-5723-06
Brand Name
Gavamin
Generic Name
Dobutamine (As Hydrochloride)
Dosage Form
Solution For Injection (Iv Infusion)
Dosage Strength
50mg/mL (250mg/5mL)
Manufacturer
Myungmoon Pharmaceutical Co., Ltd
Importer
H & B Pharma International Inc.
Distributor
Corbridge Group Phils., Inc.
Issuance Date
29 May 2023
Expiry Date
18 July 2028
Pharmacologic Category
Adrenergic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
adc42c821027aa98
Type
Standard
Back to Philippines FDA Approvals